These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 1601028)
21. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation. Nordback IH; Clemens JA; Cameron JL Surgery; 1991 Mar; 109(3 Pt 1):301-6. PubMed ID: 1705726 [TBL] [Abstract][Full Text] [Related]
22. Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. Dembiński A; Warzecha Z; Ceranowicz P; Warzecha AM; Pawlik WW; Dembiński M; Rembiasz K; Sendur P; Kuśnierz-Cabala B; Tomaszewska R; Chowaniec E; Konturek PC Eur J Pharmacol; 2008 Sep; 591(1-3):284-92. PubMed ID: 18593574 [TBL] [Abstract][Full Text] [Related]
23. Duodenal Loop Obstruction as an Unusual Cause of Acute Pancreatitis: A Case Series. Lee H; Choi Y; Jeong H; Lim JK; Jung T; Han JH; Park SM Korean J Gastroenterol; 2016 Dec; 68(6):326-330. PubMed ID: 28025477 [TBL] [Abstract][Full Text] [Related]
25. Decreased red blood cells deformability in acute pancreatitis in the rat. Effect of tirilazad mesylate. Chmiel B; Pajak J; Grabowska-Bochenek R; Cierpka L Folia Med Cracov; 2003; 44(1-2):109-15. PubMed ID: 15232892 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis. Latorre M; Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Herranz R; Del Río J; Cenarruzabeitia E Pharmacology; 2004 Oct; 72(2):68-76. PubMed ID: 15331911 [TBL] [Abstract][Full Text] [Related]
27. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction. Murayama KM; Samuel I; Toriumi Y; Solomon TE; Turkelson CM; Joehl RJ J Surg Res; 1993 Feb; 54(2):126-31. PubMed ID: 7683071 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness of interleukin-1 receptor antagonist (Anakinra) on cerulein-induced experimental acute pancreatitis in rats. Kaplan M; Yazgan Y; Tanoglu A; Berber U; Oncu K; Kara M; Demirel D; Kucuk I; Ozari HO; Ipcioglu OM Scand J Gastroenterol; 2014 Sep; 49(9):1124-30. PubMed ID: 24912987 [TBL] [Abstract][Full Text] [Related]
29. Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade. Niederau C; Borchard F; Lüthen R; Niederau M Hepatogastroenterology; 1996; 43(12):1442-53. PubMed ID: 8975946 [TBL] [Abstract][Full Text] [Related]
30. Guggulsterone attenuates cerulein-induced acute pancreatitis via inhibition of ERK and JNK activation. Kim DG; Bae GS; Choi SB; Jo IJ; Shin JY; Lee SK; Kim MJ; Kim MJ; Jeong HW; Choi CM; Seo SH; Choo GC; Seo SW; Song HJ; Park SJ Int Immunopharmacol; 2015 May; 26(1):194-202. PubMed ID: 25843255 [TBL] [Abstract][Full Text] [Related]
31. Cathepsin B inhibition in two models of acute pancreatitis. Korsten MA; Długosz JW Int J Pancreatol; 1993 Oct; 14(2):149-55. PubMed ID: 7506743 [TBL] [Abstract][Full Text] [Related]
32. The beneficial effect of propolis on cerulein-induced experimental acute pancreatitis in rats. Büyükberber M; Savaş MC; Bağci C; Koruk M; Gülşen MT; Tutar E; Bilgiç T; Deveci R; Küçük C Turk J Gastroenterol; 2009 Jun; 20(2):122-8. PubMed ID: 19530045 [TBL] [Abstract][Full Text] [Related]
33. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Kimura K; Tominaga K; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035 [TBL] [Abstract][Full Text] [Related]
34. Contribution of pancreatic edema and short-term ischemia to experimental acute pancreatitis in the rat. I. Procedure and pathomorphological investigations. Spormann H; Sokolowski A; Birkigt HG; Letko G Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):323-30. PubMed ID: 3825214 [TBL] [Abstract][Full Text] [Related]
36. Influence of bile flow interruption on acute experimental pancreatitis. Sarli L; Gafà M; Lupi M; Peracchia A Ital J Surg Sci; 1984; 14(2):119-23. PubMed ID: 6206023 [TBL] [Abstract][Full Text] [Related]
37. Standards of morphological evaluation and histological grading in experimental acute pancreatitis. Nevalainen TJ; Aho HJ Eur Surg Res; 1992; 24 Suppl 1():14-23. PubMed ID: 1601020 [TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. Niederau C; Liddle RA; Ferrell LD; Grendell JH J Clin Invest; 1986 Oct; 78(4):1056-63. PubMed ID: 2428840 [TBL] [Abstract][Full Text] [Related]
39. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein. Mazzon E; Genovese T; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Meli R; Sessa E; Cuzzocrea S Eur J Pharmacol; 2006 Nov; 549(1-3):149-56. PubMed ID: 16979620 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis in rats. Warzecha Z; Ceranowicz P; Dembinski A; Cieszkowski J; Kusnierz-Cabala B; Tomaszewska R; Kuwahara A; Kato I J Physiol Pharmacol; 2010 Aug; 61(4):419-27. PubMed ID: 20814069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]